• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIRT1-代谢物结合组蛋白巨H2A1.1保护肝细胞免受脂质积累。

SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation.

作者信息

Pazienza Valerio, Borghesan Michela, Mazza Tommaso, Sheedfar Fareeba, Panebianco Concetta, Williams Roger, Mazzoccoli Gianluigi, Andriulli Angelo, Nakanishi Tomoko, Vinciguerra Manlio

机构信息

Department of Medical Sciences, Gastroenterology Unit, IRCCS "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, Italy.

出版信息

Aging (Albany NY). 2014 Jan;6(1):35-47. doi: 10.18632/aging.100632.

DOI:10.18632/aging.100632
PMID:24473773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3927808/
Abstract

Non-alcoholic-fatty-liver-disease (NAFLD) encompasses conditions associated to fat deposition in the liver, which are generally deteriorated during the aging process. MacroH2A1, a variant of histone H2A, is a key transcriptional regulator involved in tumorigenic processes and cell senescence, and featuring two alternatively splicing isoforms, macroH2A1.1 and macroH2A1.2. MacroH2A1.1 binds with high affinity O-acetyl ADP ribose, a small metabolite produced by the reaction catalysed by NAD+-dependent deacetylase SIRT1, whereas macroH2A1.2 is unable to do so. The functional significance of this binding is unknown. We previously reported that the hepatic levels of macroH2A1.1 and macroH2A1.2 are differentially expressed in mice models of NAFLD. Here we show that over-expression of macroH2A1.1, but not of macroH2A1.2, is able to protect hepatocytes against lipid accumulation. MacroH2A1.1 over-expressing cells display ameliorated glucose metabolism, reduced expression of lipidogenic genes and fatty acids content. SIRT1/macroH2A1.1-dependent epigenetic regulation of lipid metabolism may be relevant to NAFLD development.

摘要

非酒精性脂肪性肝病(NAFLD)包括与肝脏脂肪沉积相关的病症,这些病症在衰老过程中通常会恶化。MacroH2A1是组蛋白H2A的一种变体,是参与肿瘤发生过程和细胞衰老的关键转录调节因子,具有两种可变剪接异构体,即macroH2A1.1和macroH2A1.2。MacroH2A1.1与O-乙酰ADP核糖具有高亲和力结合,O-乙酰ADP核糖是一种由NAD+依赖性脱乙酰酶SIRT1催化的反应产生的小代谢物,而macroH2A1.2则不能。这种结合的功能意义尚不清楚。我们之前报道过,在NAFLD小鼠模型中,macroH2A1.1和macroH2A1.2的肝脏水平存在差异表达。在此我们表明,macroH2A1.1的过表达而非macroH2A1.2的过表达能够保护肝细胞免受脂质积累。过表达macroH2A1.1的细胞表现出改善的葡萄糖代谢、脂质生成基因表达降低以及脂肪酸含量降低。SIRT1/macroH2A1.1依赖性的脂质代谢表观遗传调控可能与NAFLD的发展有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc5/3927808/df064fdbca59/aging-06-035-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc5/3927808/0553455566ec/aging-06-035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc5/3927808/7183c19138fa/aging-06-035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc5/3927808/859100d2e3f8/aging-06-035-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc5/3927808/c1c94cb67d2a/aging-06-035-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc5/3927808/df064fdbca59/aging-06-035-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc5/3927808/0553455566ec/aging-06-035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc5/3927808/7183c19138fa/aging-06-035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc5/3927808/859100d2e3f8/aging-06-035-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc5/3927808/c1c94cb67d2a/aging-06-035-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc5/3927808/df064fdbca59/aging-06-035-g005.jpg

相似文献

1
SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation.SIRT1-代谢物结合组蛋白巨H2A1.1保护肝细胞免受脂质积累。
Aging (Albany NY). 2014 Jan;6(1):35-47. doi: 10.18632/aging.100632.
2
MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis.MacroH2A1亚型与脂肪性肝脂肪变性中脂肪生成基因激活的表观遗传标记有关。
FASEB J. 2015 May;29(5):1676-87. doi: 10.1096/fj.14-262717. Epub 2014 Dec 19.
3
Splicing regulates NAD metabolite binding to histone macroH2A.剪接调节NAD代谢物与组蛋白macroH2A的结合。
Nat Struct Mol Biol. 2005 Jul;12(7):624-5. doi: 10.1038/nsmb956. Epub 2005 Jun 19.
4
Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.组蛋白macroH2A1 异构体的免疫阳性标记与脂肪变性相关的肝细胞癌。
PLoS One. 2013;8(1):e54458. doi: 10.1371/journal.pone.0054458. Epub 2013 Jan 23.
5
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.miR-122 通过靶向 Sirt1 抑制 LKB1/AMPK 通路促进非酒精性脂肪性肝病中的肝脂肪生成。
Mol Med. 2019 Jun 13;25(1):26. doi: 10.1186/s10020-019-0085-2.
6
DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.DNA低甲基化与组蛋白变体macroH2A1协同减弱化疗诱导的衰老以促进肝细胞癌进展。
Cancer Res. 2016 Feb 1;76(3):594-606. doi: 10.1158/0008-5472.CAN-15-1336. Epub 2016 Jan 15.
7
Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.肝细胞中 SIRT1 的缺失会破坏脂联素-1 信号通路并加重酒精性脂肪肝。
Gastroenterology. 2014 Mar;146(3):801-11. doi: 10.1053/j.gastro.2013.11.008. Epub 2013 Nov 18.
8
Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells.mir-23b对SIRT1表达的下调促进了HepG2细胞中的脂质积累。
Biochem Genet. 2019 Aug;57(4):507-521. doi: 10.1007/s10528-019-09905-5. Epub 2019 Jan 29.
9
LB100 ameliorates nonalcoholic fatty liver disease the AMPK/Sirt1 pathway.LB100 通过 AMPK/Sirt1 通路改善非酒精性脂肪性肝病。
World J Gastroenterol. 2019 Dec 7;25(45):6607-6618. doi: 10.3748/wjg.v25.i45.6607.
10
Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.漆黄素通过调节高脂肪饮食诱导的肥胖小鼠中的Sirt1/AMPK和脂肪酸β-氧化信号通路来预防肝脂肪变性。
Cell Physiol Biochem. 2018;49(5):1870-1884. doi: 10.1159/000493650. Epub 2018 Sep 20.

引用本文的文献

1
Role of cellular senescence in hepatic diseases (Review).细胞衰老在肝脏疾病中的作用(综述)
Int J Mol Med. 2025 Nov;56(5). doi: 10.3892/ijmm.2025.5623. Epub 2025 Sep 5.
2
Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma.儿童H3K27改变的弥漫性中线胶质瘤的细胞外组蛋白谱
Mol Diagn Ther. 2025 Jan;29(1):129-141. doi: 10.1007/s40291-024-00754-6. Epub 2024 Nov 8.
3
The Function of H2A Histone Variants and Their Roles in Diseases.组蛋白变体 H2A 的功能及其在疾病中的作用。

本文引用的文献

1
The histone variant MacroH2A regulates Ca(2+) influx through TRPC3 and TRPC6 channels.组蛋白变体 MacroH2A 通过调节 TRPC3 和 TRPC6 通道来控制 Ca(2+)内流。
Oncogenesis. 2013 Oct 28;2(10):e77. doi: 10.1038/oncsis.2013.40.
2
Liver diseases and aging: friends or foes?肝脏疾病与衰老:是敌是友?
Aging Cell. 2013 Dec;12(6):950-4. doi: 10.1111/acel.12128. Epub 2013 Jul 30.
3
Epigenomics and the regulation of aging.表观基因组学与衰老调控。
Biomolecules. 2024 Aug 12;14(8):993. doi: 10.3390/biom14080993.
4
Detection of cell-free histones in the cerebrospinal fluid of pediatric central nervous system malignancies by imaging flow cytometry.通过成像流式细胞术检测小儿中枢神经系统恶性肿瘤脑脊液中的游离组蛋白。
Front Mol Biosci. 2023 Nov 1;10:1254699. doi: 10.3389/fmolb.2023.1254699. eCollection 2023.
5
Deficiency of histone variant macroH2A1.1 is associated with sexually dimorphic obesity in mice.组蛋白变体宏 H2A1.1 的缺乏与小鼠的性别二态性肥胖有关。
Sci Rep. 2023 Nov 5;13(1):19123. doi: 10.1038/s41598-023-46304-8.
6
Profiling of cell-free DNA methylation and histone signatures in pediatric NAFLD: A pilot study.儿童非酒精性脂肪性肝病游离 DNA 甲基化和组蛋白特征分析:一项初步研究。
Hepatol Commun. 2022 Dec;6(12):3311-3323. doi: 10.1002/hep4.2082. Epub 2022 Oct 20.
7
Histone Variant macroH2A1.1 Enhances Nonhomologous End Joining-dependent DNA Double-strand-break Repair and Reprogramming Efficiency of Human iPSCs.组蛋白变体 macroH2A1.1 增强了人诱导多能干细胞中非同源末端连接依赖的 DNA 双链断裂修复和重编程效率。
Stem Cells. 2022 Mar 3;40(1):35-48. doi: 10.1093/stmcls/sxab004.
8
The Histone Variant MacroH2A1 Impacts Circadian Gene Expression and Cell Phenotype in an In Vitro Model of Hepatocellular Carcinoma.组蛋白变体MacroH2A1在肝癌体外模型中影响昼夜节律基因表达和细胞表型。
Biomedicines. 2021 Aug 20;9(8):1057. doi: 10.3390/biomedicines9081057.
9
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels.通过恢复 miRNA-217 水平提高胰腺癌细胞对吉西他滨的敏感性。
Biomolecules. 2021 Apr 26;11(5):639. doi: 10.3390/biom11050639.
10
The Versatility of Sirtuin-1 in Endocrinology and Immunology.沉默调节蛋白1在内分泌学和免疫学中的多功能性
Front Cell Dev Biol. 2020 Nov 19;8:589016. doi: 10.3389/fcell.2020.589016. eCollection 2020.
Epigenomics. 2013 Apr;5(2):205-27. doi: 10.2217/epi.13.5.
4
MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency.组蛋白变体 MacroH2A 在重编程为多能性时起到了障碍作用。
Nat Commun. 2013;4:1565. doi: 10.1038/ncomms2582.
5
Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.组蛋白macroH2A1 异构体的免疫阳性标记与脂肪变性相关的肝细胞癌。
PLoS One. 2013;8(1):e54458. doi: 10.1371/journal.pone.0054458. Epub 2013 Jan 23.
6
Depletion of nuclear histone H2A variants is associated with chronic DNA damage signaling upon drug-evoked senescence of human somatic cells.核组蛋白H2A变体的耗竭与人类体细胞药物诱发衰老时的慢性DNA损伤信号传导相关。
Aging (Albany NY). 2012 Nov;4(11):823-42. doi: 10.18632/aging.100507.
7
Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD).氧化还原平衡和非酒精性脂肪性肝病 (NAFLD) 的表观遗传学。
Curr Pharm Des. 2013;19(15):2737-46. doi: 10.2174/1381612811319150009.
8
Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness.RNA 解旋酶对表观遗传调控因子剪接开关的调控促进肿瘤细胞的侵袭性。
Nat Struct Mol Biol. 2012 Nov;19(11):1139-46. doi: 10.1038/nsmb.2390. Epub 2012 Sep 30.
9
The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease.聚腺苷二磷酸核糖聚合酶-1 和聚腺苷二磷酸核糖聚合酶-2 酶在代谢调节和疾病中的作用。
Cell Metab. 2012 Sep 5;16(3):290-5. doi: 10.1016/j.cmet.2012.06.016. Epub 2012 Aug 23.
10
Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer.MacroH2A1 异构体在结肠癌中的差异调控及预测潜能。
Am J Pathol. 2012 Jun;180(6):2516-26. doi: 10.1016/j.ajpath.2012.02.027. Epub 2012 Apr 27.